[ Price : $8.95]
FDA approves a Supernus Pharmaceuticals label update for attention-deficit/hyperactivity disorder drug Qelbree (viloxazine extende...[ Price : $8.95]
Provepharm recalls one lot of phenylephrine hydrochloride injection, USP, 10 mg/mL due to a customer complaint about visible black...[ Price : $8.95]
FDA approves an Eisai/Biogen supplemental BLA for Leqembi (lecanemab-irmb) and its intravenous use once every four weeks as mainte...[ Price : $8.95]
Pfizer agrees to pay $59.7 million to resolve allegations that its subsidiary, Biohaven Pharmaceutical, engaged in previous illega...[ Price : $8.95]
Vanda Pharmaceuticals files an NDA for tradipitant for treating motion sickness.[ Price : $8.95]
ALX Oncology plans to discuss with FDA its path for seeking accelerated approval for CD47-blocker evorpacept based on positive upd...[ Price : $8.95]
FDA approves a Medexus NDA for Grafapex (treosulfan) for use with fludarabine as a preparative regimen for allogeneic hematopoiet...[ Price : $8.95]
Responding to a Trump Administration order, FDA delays the effective date until 3/21 of a recent final rule entitled Nonprescripti...